Omnes Capital

PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.

Opensee is a Paris-based fintech company that specializes in providing self-service analytics solutions for financial institutions. Founded by a team of experts from the financial and technology sectors, Opensee addresses the challenges posed by big data by enabling organizations to efficiently analyze vast quantities of data on demand. The platform allows business users to perform in-depth analyses and what-if scenarios, facilitating better decision-making in areas such as risk management in capital markets and resource management in commercial and retail banking. By transforming complex data into actionable insights, Opensee empowers financial institutions to enhance their market intelligence and streamline regulatory reporting processes.

Gourmey is a pioneering cultivated meat company based in Paris, France, founded in 2019. It specializes in the development and production of ethical foie gras derived from duck cells, aiming to revolutionize the traditional foie gras industry. By utilizing a lab-based approach, Gourmey cultivates meat without the need for force-feeding or slaughter, ensuring a more humane and sustainable alternative. The company places duck cells in a controlled environment, providing optimal temperature, essential nutrients, and space for growth, which results in a product that prioritizes consumer health, environmental sustainability, and animal welfare.

Qubit Pharmaceuticals is a Paris-based company established in 2020, focusing on innovative technology for pharmaceutical drug discovery. Founded by prominent academic institutions and researchers, including CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, the company leverages over 20 years of research and development. Qubit Pharmaceuticals has developed a drug discovery simulation platform that aims to significantly reduce the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform facilitates virtual screening and visualization of potential drug candidates. By integrating principles of quantum physics, Qubit Pharmaceuticals supports biopharmaceutical companies in accelerating their research and development processes, ultimately enhancing the efficiency of drug discovery.

PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.

AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Teach on Mars SAS is a leading provider of mobile learning technology based in Sophia Antipolis, France, with additional offices in Paris, Milan, and London. Founded in 2013, the company has established itself as a prominent player in the mobile learning sector, delivering solutions to over 100 clients in more than 60 countries and in 20+ languages. The platform enables organizations to create mobile courses and learning games, manage training programs, and analyze learner progress through comprehensive analytics. Teach on Mars offers various applications, including Learn on Mars for personalized learning experiences and Quiz on Mars, which promotes engagement through social learning games. Additionally, the company provides training, certification, and support services, as well as integration and professional content marketplace solutions. With a dedicated team and a global network of partners, Teach on Mars aims to equip organizations with the necessary tools and expertise to develop effective learning ecosystems while committing 1% of its revenues to education initiatives aligned with the UN Sustainable Development Goals.

Intersec SA, established in 2004, is a global technology company headquartered in Paris, France, with an additional office in London, UK. It specializes in providing streaming analytics solutions to various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Intersec's offerings encompass customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. The company's solutions enable organizations to derive real-time insights from vast amounts of data, helping them to optimize operations, enhance customer experiences, and drive new revenue streams. Intersec serves over 90 clients across 40 countries, reaching nearly one billion connected devices and covering over 400 million people with its mission-critical communication solutions. Recognized by Gartner as a leading vendor in location intelligence and telecom data monetization, Intersec prioritizes privacy and regulatory compliance, ensuring it operates responsibly worldwide.

Tiller Systems SAS is a Paris-based company that specializes in developing cloud-based point of sale (POS) software solutions for restaurants and merchants. Founded in March 2014, Tiller's management tools enable users to accept various payment types, integrate partner applications, and effectively oversee staff and inventory in real time. The software features a mobile POS system that allows for the management of both in-store and online orders from a single platform. Additionally, Tiller offers a web dashboard that facilitates catalog updates, sales tracking, employee payments, stock alerts, customer relationship management, and access to real-time reporting and performance metrics. With additional offices in Barcelona and Milan, Tiller Systems aims to empower businesses to make informed decisions and enhance their operational efficiency.

S.A. Nanomakers is a Paris-based company established in 2010 that focuses on the design, manufacturing, and marketing of silicon-based nanomaterials, particularly nanopowders. These patented, nano-scale powders serve to significantly enhance the mechanical, thermal, and chemical properties of various industrial materials, including metal alloys and elastomers. Nanomakers' silicon carbide and silicon nanopowders play a crucial role in advancing sectors such as semiconductors, energy storage, aerospace, and automotive. The company's innovative materials double the energy storage density of lithium-ion batteries by utilizing nano-composites, thereby positioning Nanomakers at the forefront of technology that drives performance improvements across multiple industries.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Intersec SA, established in 2004, is a global technology company headquartered in Paris, France, with an additional office in London, UK. It specializes in providing streaming analytics solutions to various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Intersec's offerings encompass customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. The company's solutions enable organizations to derive real-time insights from vast amounts of data, helping them to optimize operations, enhance customer experiences, and drive new revenue streams. Intersec serves over 90 clients across 40 countries, reaching nearly one billion connected devices and covering over 400 million people with its mission-critical communication solutions. Recognized by Gartner as a leading vendor in location intelligence and telecom data monetization, Intersec prioritizes privacy and regulatory compliance, ensuring it operates responsibly worldwide.

AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Pixium Vision SA is a bioelectronics company based in Paris, France, focused on developing innovative implantable medical devices aimed at restoring vision for individuals blinded by the degeneration of photoreceptor cells in the retina. The company’s flagship product, the PRIMA System, is a bionic vision system designed to improve visual acuity and enhance the independence of patients. Pixium Vision also works on the Intelligent Retinal Implantable System (IRIS1), which is currently undergoing clinical trials, and is developing two subsequent generations, IRIS2 and IRIS3, each designed to provide improved visual capabilities through advanced technologies. Founded in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with prestigious institutions such as Stanford University and Moorfields Eye Hospital to further its research and development efforts in retinal implant systems.

Greenbureau SA is a Paris-based company founded in 2011 that operates an online platform designed to enhance personal finance management and streamline customer interactions. The platform centralizes invoices and statements from major suppliers and public services in France, allowing users to automatically retrieve their financial documents and manage them through a single login. In addition to digital billing and invoicing, Greenbureau offers services such as Zen Call, Zen Care, and Call Bot, which are designed to improve customer communication and reduce waiting times. By facilitating budgeting, providing time and alert options, and offering unlimited storage, Greenbureau aims to simplify the customer experience while helping businesses reduce management costs through increased digital engagement. The company generates revenue through partnerships with major providers, allowing it to offer its services free of charge to users.

Ividence, Inc. is an email advertising platform that connects advertisers with publishers to optimize email marketing campaigns. Founded in 2008 and headquartered in Paris, France, with additional offices in New York and San Francisco, Ividence offers a comprehensive email advertising exchange platform. This platform utilizes behavioral targeting technology to deliver tailored advertising content to specific audiences, enhancing the effectiveness of email campaigns. Ividence also focuses on maintaining list hygiene and managing user feedback, including unsubscribe requests and complaints. By providing real-time reporting and CRM retargeting capabilities, the company enables advertisers to optimize their campaigns for lead generation and customer conversion while allowing publishers to monetize their newsletters effectively.

Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

Aldebaran Robotics, established in 2005 and headquartered in Paris, France, specializes in the design, manufacture, and sale of autonomous humanoid robots. Their product portfolio includes NAO, a 58-cm tall companion robot capable of moving, recognizing, hearing, and speaking to humans; Pepper, a social robot that engages in conversation, recognizes individuals, responds to emotions, and navigates autonomously; and Romeo, a 140-cm humanoid robot designed for research into assistance for the elderly and those with mobility challenges, featuring advanced capabilities such as door opening, stair climbing, and object manipulation. The company's robots are employed in entertainment, reception, assistance, home care, and autism therapy applications.

ConfortVisuel is an online retailer specializing in optical products, catering to a diverse clientele with a broad range of offerings. With five years of experience and a customer base of 12,000, the company has established itself as a significant player in the market. Its website is designed for smooth navigation, emphasizing user experience. ConfortVisuel provides economical optical products that are tested and adaptable to individual sight requirements. Additionally, the company offers a rental service, allowing visually impaired customers to test and adapt visual aids before making a purchase. Unique to ConfortVisuel is its ability to facilitate third-party online payments and the presence of a showroom in Paris, enhancing customer convenience and engagement.

Aquafadas specializes in digital publishing technology that facilitates the creation and distribution of interactive digital content, including magazines, newspapers, corporate documents, books, and comics, across various platforms such as smartphones, tablets, and the web. The company provides tailored content creation and distribution solutions, helping businesses enhance their digital publishing strategies while reducing costs. Its client roster includes notable names like Lagardère, Mondadori, and Vodafone. Aquafadas is also recognized for its role in advancing digital publishing standards through memberships in organizations like the International Digital Publishing Forum and IdeAlliance. As part of the Rakuten group, it also contributes its expertise to Kobo, a leading e-reader provider. With offices in Montpellier, Paris, and New York, Aquafadas continues to develop innovative tools and applications for mobile-first audiences, focusing on improving engagement and efficiency for its clients.

Sparus Software is a Paris-based independent software vendor specializing in mobile device management solutions. The company designs and develops the EveryWAN Mobility Manager, a comprehensive software suite that allows enterprises to effectively deploy and manage mobile handheld devices over various wireless networks, including GPRS, Edge, 3G, and WiFi. By streamlining the management of mobile devices, Sparus Software helps organizations reduce operating expenses while enhancing operational efficiency.

Groupe Frères Blanc is a prominent player in the French gastronomy sector, operating a network of 15 esteemed restaurants and brasseries in Paris, Provence, and internationally. Established in the 1950s by brothers Pierre and Jacques Blanc, the group has built a reputation for exceptional dining experiences, showcasing quality cuisine and the French art de vivre. In addition to its restaurant operations, the company also offers online reservation services for both individual and group bookings, enhancing customer convenience. Based in Paris, Groupe Frères Blanc continues to be a significant influence in the culinary landscape of France.

Leyton is a consulting firm headquartered in Paris, France, founded in 1997. Specializing in cost optimization, Leyton provides a range of services including tax credit research, start-up consulting, purchase optimization, insurance audits, and management of receipts. The firm has developed significant expertise in optimizing Federal and State Research and Development (R&D) Tax Credits in the United States. With over 20 years of global experience, Leyton boasts a team of highly qualified tax professionals and technical consultants, making it one of the largest innovation funding specialists worldwide. The firm serves a diverse array of industries, including software, engineering, manufacturing, food and beverage, and architecture, ensuring that its clients benefit from tailored insights and solutions. Leyton’s commitment to technical knowledge is exemplified by its substantial team dedicated to R&D Tax claims, allowing for maximized claims and informed guidance based on industry-specific challenges.

OpenTrust is a company that designs and develops versatile solutions aimed at addressing complex security challenges in modern enterprises. Founded in 2000 and based in Paris, France, OpenTrust provides a range of software products and cloud security services to governments, financial institutions, and enterprises, facilitating the management of digital identities and securing electronic transactions and documents. Its offerings include certificate-based strong authentication, smart card management, secure document exchange, digital signatures, and proof management. The OpenTrust platform is compatible with various technologies from leading vendors and is available both as licensed software and private cloud services. Additionally, OpenTrust provides professional services to assist in product integration and offers a comprehensive training and certification program. Its solutions are utilized by numerous multinational enterprises, with more than 2 billion users across 100 countries.

Interactif Visuel Système is a Paris-based company founded in 1996 that specializes in developing and marketing computer software. The firm focuses on creating innovative sales aid systems tailored for the optic, ophthalmologic, and cosmetic industries. By providing technological support services specifically for opticians, Interactif Visuel Système aims to enhance the sales process and customer engagement within these markets.